Risk factors for blunt cerebrovascular injury in the pediatric patient: A systematic review
American Journal of Emergency Medicine 71 (2023) 37-46
Contents lists available at ScienceDirect
American Journal of Emergency Medicine
journal homepage:
Risk factors for blunt cerebrovascular injury in the pediatric patient: A systematic review
Madison Schulz, BA a,?, Veronica Weihing, BS b, Manish N. Shah, MD c, Charles S. Cox Jr., MD d, Irma Ugalde, MD e
a McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 361-947-1354, USA
b McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA
c Division of Pediatric Neurosurgery, Department of Pediatric Surgery, McGovern Medical School, The University of Texas Health Science Center, Houston, Houston, TX, USA
d Department of Pediatric Surgery, McGovern Medical School, The University of Texas Health Science Center, Houston, Houston, TX, USA
e Department of Emergency Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA
a r t i c l e i n f o
Article history:
Received 20 April 2023
Received in revised form 25 May 2023 Accepted 3 June 2023
Keywords:
Pediatric Trauma Risk factor
Blunt cerebrovascular injury Stroke
a b s t r a c t
Background: While blunt cerebrovascular injury (BCVI) is a rare complication of blunt trauma, it is associated with significant morbidity and mortality. In the pediatric population, unique anatomy and development require screening criteria that accurately diagnose these injuries while limiting unwarranted radiation.
Methods: We searched Medline OVID, EMBASE, and Cochrane Library databases for studies that investigated the risk factors of BCVI in individuals younger than 18 years of age. We adhered to the Preferred Reporting Items in Systematic Reviews and Meta-Analyses (PRISMA) guidelines and assessed the quality of each study using the Newcastle-Ottawa Scale. We compared key characteristics of the papers, including incidence of BCVI, incidence of risk factors, and statistical significance of risk factors.
Results: Of 1304 studies, 16 met the inclusion criteria. Of these, 15 were retrospective cohort studies and one was a retrospective case control study. Most of the studies included all pediatric blunt trauma admissions, but four only included those which underwent imaging, one only included those with cervical seatbelt sign, and one excluded those who did not survive 24-h post-admission. The ages included as pediatric varied between papers. Papers examined different risk factors and reported differing statistical significances. Though no single risk factor was found to be statistically significant in every study, cervical spine and Skull fractures were found to be signif- icant by most. MaxilloFacial fractures, depressed GCS score, and stroke were found to be statistically significant by multiple studies. Twelve studies examined cervical soft tissue injury, and none found it to be statistically significant.
Conclusions: The risk factors most found to be statistically significant for BCVI were cervical spine fracture (10/16 studies), skull fracture (9/16), maxillofacial fractures (7/16), depressed GCS score (5/16), and stroke (5/16). There is a need for prospective studies on this topic.
Level of evidence: Level III, Systematic Review.
(C) 2023
Though the true incidence of blunt cerebrovascular injury (BCVI) in Pediatric trauma patients is debated; the severe consequences of this in- jury have been a stimulus for research in the past decade. One area that has been investigated is risk factors of BCVI. This is of particular impor- tance because the most widely used-diagnostic test for BCVI, CT angiog- raphy, involves radiation exposure [1]. Children are significantly more
E-mail addresses: [email protected] (M. Schulz), [email protected] (V. Weihing), [email protected] (M.N. Shah), [email protected] (C.S. Cox), [email protected] (I. Ugalde).
vulnerable to complications of radiation on account of their small body size and increased chance of lifetime exposure [2]. While avoiding unnecessary CTA in children is an important goal, diagnosing BCVI is critical due to the potential complication of strokes and other serious Neurological sequelae [3]. Many of these adverse Neurologic events can be silent, occurring hours to days after an injury [3]. Timely diagno- sis allows for early therapy that may reduce the incidence of stroke, making effective screening for children at risk for BCVI paramount [4,5]. Currently, there are several screening criteria for BCVI that include different risk factors. Earlier Screening tools, including the Denver criteria, Memphis criteria, and EAST criteria, were not derived in pediat- ric populations, but have been applied to children [4]. More recently, screening criteria such as the Utah and McGovern scores were created
https://doi.org/10.1016/j.ajem.2023.06.006
0735-6757/(C) 2023
M. Schulz, V. Weihing, M.N. Shah et al. American Journal of Emergency Medicine 71 (2023) 37-46
specifically for screening for BCVI in children. Screening criteria is het- erogeneous, often dependent on the institution at which it was derived. We hypothesize that examination of the literature will reveal common risk factors for pediatric BCVI that can be used to optimize
screening for this type of injury.
- Methods
- Design
We conducted a systematic review according to Preferred Reporting Items in Systematic Reviews and Meta-Analyses (PRISMA) guidelines [6]. Using a pre-determined protocol, we performed a systematic search of the OVID Medline, EMBASE, and Cochrane Library databases. All data- bases were last searched in January 2023. The search protocol for this systematic review was registered with the University of York Center
for Reviews and Dissemination of the National Institute for Health Research PROSPERO database (registration no. CRD42022308691).
-
- Selection of studies
The search strategy is summarized in Appendix A. We structured our search around the population, intervention, comparison, outcome (PICO) framework to address the question, “What are the risk factors for blunt cerebrovascular injury in pediatric patients?” [7] We identified studies evaluating the association of several different screening criteria with incidence of BCVI. We did not include studies which did not exam- ine risk factors in relation to incidence of BCVI. Eligible studies included randomized control trials, non-randomized control trials, and retro- spective or prospective cohort studies. We limited the search to those including children <=18 years. We excluded case reports, opinion pieces, review articles, and studies involving non-human subjects. We did not
38
M. Schulz, V. Weihing, M.N. Shah et al.
American Journal of Emergency Medicine 71 (2023) 37-46
39
Source summaries.
Outcome/Control Newcastle-Ottawa scale appraisal
Source |
Design |
Population |
BCVI |
Sample size (number of patients) |
Prevalence |
Selection |
Comparability |
Outcome |
Total |
||
Azarakhsh Cook |
Retrospective cohort Retrospective cohort |
blunt trauma patients <15 years old admitted to six level 1 trauma centers between October 2009 and June 2011 blunt trauma patients <=18 years treated at level 1 trauma center from 2005 to 2015 |
27 BCVI in 23 patients 128 BCVI in 96 |
5829 7440 |
0.4% 1.3% |
4 4 |
0 0 |
3 3 |
7 7 |
||
Desai |
Retrospective cohort |
blunt trauma patients <18 years old at two pediatric trauma centers between March 2002 and |
patients 9 BCVI in 8 |
137 |
5.8% |
4 |
0 |
3 |
7 |
||
Dewan |
Retrospective cohort |
November 2012 who underwent CTA of the neck patients <18 years old who underwent CTA evaluation of the head or neck for suspected |
patients 57 BCVI in 52 |
645 |
8.1% |
4 |
0 |
3 |
7 |
||
traumatic BCVI at 4 pediatric trauma centers from 2003 to 2013 |
patients |
||||||||||
Farzaneh |
Retrospective cohort |
blunt trauma patients <= 18 years from National Trauma Data Bank from 2007 to 2015 |
1998 patients |
885,100 |
0.2% |
4 |
0 |
3 |
7 |
||
Grigorian Herbert |
Retrospective cohort Retrospective cohort |
blunt trauma patients <16 years old registered in the Pediatric Trauma Quality Improvement Program from 2014 to 2016 blunt trauma patients <=15 years treated at level I trauma center between 2005 and 2015 |
109 patients 21 patients |
69,149 12,614 |
<0.2% 0.17% |
4 4 |
1 0 |
3 3 |
8 7 |
||
Kopelman |
Retrospective cohort |
blunt trauma patients <15 years presenting over a 5-year period at level 1 trauma center |
14 BCVI in 11 |
1209 patients |
0.9% |
4 |
0 |
3 |
7 |
||
Leraas |
Retrospective cohort |
Blunt trauma patients <=18 years registered in the national trauma data bank from 2008 to 2014 |
patients 809 patients |
422,181 patients |
19.2 per |
4 |
2 |
3 |
9 |
||
Mallicote |
Retrospective cohort |
blunt trauma patients <=18 years presenting at level 1 trauma center from 2005 to 2013; blunt |
1 patient;2136 |
2795 patients; |
10,000 cases 0.03%; |
4 |
2 |
3 |
9 |
||
trauma patients <=18 years in National Trauma Data Bank from 2007 to 2014 |
patients |
776,355 patients |
0.27% |
||||||||
Ravindra (2015) Rossidis |
Retrospective cohort Retrospective case |
patients <18 years who underwent CTA during examination for BCVI at Primary Children’s Hospital from 2003 to 2013 blunt trauma patients <=18 years evaluated at The Children's Hospital of Philadelphia from |
37 BCVIs in 36 patients 11 patients |
234 patients 11,596 patients |
15.4% 0.095% |
4 4 |
0 2 |
3 3 |
7 9 |
||
Savoie |
control Retrospective cohort |
January 2005 to January 2015. blunt trauma patients <18 years old registered in National Trauma Data Bank from 2007 to |
1682 patients |
732,702 patients |
0.2% |
4 |
0 |
3 |
7 |
||
Tolhurst |
Retrospective cohort |
2014 patients 4-18 years evaluated for blunt cervical spine trauma from 1998 to 2008 |
7 patients |
61 patients |
11.5% |
4 |
0 |
3 |
7 |
||
Ugalde |
Retrospective cohort |
Blunt trauma patients <18 years at level 1 trauma center from November 2002-December 2014 |
53 patients |
11,446 patients |
0.4% |
4 |
1 |
3 |
8 |
||
Weber |
Retrospective cohort?? |
Blunt trauma patients <18 years with ISS > 9 from 2002 to 20,015 |
42 patients |
8128 patients |
0.5% |
4 |
0 |
3 |
7 |
include abstracts. We did not exclude studies based on date of publica- tion, language, or country of origin.
-
- Appraisal of studies
Two reviewers identified relevant studies through a review of titles and abstracts against the exclusion criteria. A third reviewer resolved discrepancies. The same two appraisers completed a full-text review of all identified studies to confirm study inclusion. The reviewers ap- praised the quality of each selected study using the Newcastle-Ottawa Scale for non-randomized cohort studies and case control studies as appropriate. The Newcastle-Ottawa Scale awards points for methodo- logical quality. A third reviewer resolved discrepancies.
The reviewers aligned the interpretation of the Newcastle-Ottawa Scale score among the chosen studies to ensure consistency [8]. For rep- resentativeness, if a study included blunt trauma patients cared for in hospital, we considered the study to be “truly representative of the av- erage pediatric blunt trauma patient with potential BCVI in the commu- nity.” For ascertainment of exposure, we considered trauma registries and electronic medical records as “secure records.” For “demonstration that outcome of interest was not present at the start of the study, we assigned all studies as “yes.” For comparability, we assigned 1 point if a study controlled for one factor, two points if the study controlled for
>1 factor, and 0 points if the study did not adjust for any factors. For assessment of outcome, we accepted registries and medical records as “independent blind assessment.” We assumed that all studies had adequate follow-up for our primary outcome of BCVI to be identified.
-
- Data extraction
Two reviewers extracted data from each of the identified papers. Data extracted included study design, population, and sample size, and overall incidence of BCVI. For each of the papers, we determined which potential risk factors for BCVI were examined and what the association with each of these risk factors were with incidence of BCVI. Discrepancies were discussed and resolved by the reviewers.
Our a priori plan was to perform a meta-analysis of associations between screening criteria and incidence of BCVI if the systematic review indicated a range of studies with suitable structure and quality.
Outcomes were displayed in Tables C\\D as 1. incidence of each risk factor among known BCVI cases and 2. incidence of BCVI among those with each risk factor.
- Results
Of the 1304 citations identified in the search, 16 studies (reporting on 1,374,676 patients) met the eligibility criteria of the systematic re- view (Fig. 1 A; Table 1, Table 2). All studies were available in English. The types of study designs included retrospective cohorts (n = 15) and a retrospective case control study (n = 1). All studies were con- ducted at institutions in the United States. All studies measuring gender involved mostly male patients (range = 54.7% - 90.9%), and all patients were under the age of 18 years.
There was variation in the patient inclusion criteria between the studies. While the majority of studies included all patients admitted for blunt trauma evaluation, four of the studies included only those who had imaging such as CTA or MRI done [5,9-11]. One study excluded patients who did not survive 24 h post admission [4]. While all studies included pediatric patients, the specific ages varied between studies. Five studies included patients <= to 18 years [4,12-15], six studies in- cluded patients <18 [5,9,10,16-18], one study included patients <16 [19], one study included patients <=15 [20], two included those <15 [21,22], and one study included only those 4-18 years old [23].
All studies examined the incidence of BCVI as an outcome in their patient population, but there was significant variation in the poten- tial risk factors for BCVI examined by each of the studies. Risk factors examined included injuries to the head and neck: cervical Spinal injury, seatbelt sign, basilar skull fracture, Le Fort II/III fracture, maxillofacial fracture, mandible fracture, facial injury, Intracranial injury, fracture through carotid canal, petrous Temporal bone frac- ture, cervical cord injury w/o fracture, Diffuse axonal injury, scalp degloving, epistaxis, Jugular venous injury, clothesline injury. Some risk factors included specific neurologic signs, such as focal neurolo- gic deficit, GCS <=8 or < 8, Rotterdam score > 3, stroke on imaging, aniscoria, and cranial nerve injury. Other risk factors included systemic signs such as ISS >15, hypotension on admission, and sig- nificant blood loss. Others included injuries to other parts of the body, such as extremity fracture, upper or lower extremity injury, scapula fracture, Abdominal injury, pelvic injury, thoracic fracture, thoracic/chest injury, spinal injury, lumbar fracture, blunt cardiac in- jury, clavicle fracture, and rib fracture. The mechanism of motor
Summary of statistical significance of risk factors.
Source Risk Factor Summary
Azarakhsh No statistical analysis available. Cook No statistical analysis available.
Desai No single risk factor for BCVI met statistical significance except for GCS score. Mean GCS score significantly lower (P = 0.02) in the BCVI group vs the non-BCVI group
Dewan No statistical analysis available.
Farzaneh Skull fracture, extremity fractures, and vertebral injuries were associated with an increased risk for BCVI.
Grigorian Factors independently associated with BCVI include skull base fracture, cervical spine fracture, intracranial hemorrhage, GCS <=8, and mandible fracture. MVC not an independent predictor.
Herbert Factors statistically significantly associated with BCVI include focal neurological deficit, carotid canal fracture, petrous temporal bone fracture, cerebral infarction, and automobile-pedestrian accident.
Kopelman Basilar skull fracture, cervical spine fracture, and GCS score </= 8 was all found to be statistically significant risk factors for the presence of a BCVI. The highest risk of having a BCVI was the presence of a concerning neurologic examination.
Leraas Pediatric patients did not experience correlation between BCVI and cervical soft tissue injury. All other examined risk factors were statistically significant.
Mallicote Basilar skull fracture, cervical spine fracture, cervical fracture, cervical cord injury, cervical subluxation/dislocation, jugular venous injury, thoracic vascular injury, and cranial nerve injury are all associated with BCVI.
Ravindra (2015 finding) - GCS <8, focal neurologic deficit, carotid canal fracture, petrous temporal bone fracture and stroke on imaging are independent risk factors for BCVI.
Rossidis The independent risk factors significantly associated with BCVI were cervical spine fracture, male gender, Le Fort II or III facial fracture, and ISS. Savoie Cervical spine fracture, skull base fracture, diffuse axonal injury, Le Fort II/III fracture, mandible fracture associated with BCVI.
Tolhurst Cervical spine fracture extension to transverse foramina, fracture/dislocations or severe subluxations, or C1-C3 injury associated with increased rates of BCVI. Ugalde Independent predictors associated with BCVI were ISS >=16, infarct on head imaging, hanging mechanism, cervical spine fracture, and basilar skull fracture.
Weber Independent predictors associated with an increased risk of BCVI include cervical spine injury, facial injury, basilar skull fracture, and ISS.
Table 3
Number of patients with BCVI who had each risk factor.
Source |
Risk Factor |
Outcomes |
|||||||||
Cervical spinal |
Basilar skull |
GCS (12) |
Soft tissue |
Stroke on |
Motor Vehicle |
Le Fort II/III |
Neurologic |
Stroke (12) |
|||
injury (16) |
fracture (13) |
injury of the |
imaging* (12) |
Collision/Accident |
fracture |
Deficit (7 |
|||||
neck (ie. |
(12) |
(midfacial |
or 8) |
||||||||
seatbelt sign) |
fracture) (10) |
||||||||||
(12) |
|||||||||||
Azarakhsh |
1/23 (4.3%) |
7/23 (30.4%) |
- |
4/23 (17.4%) |
6/23 (26.1%) |
- |
0/23 (0%) |
0/23 (0%) |
6/23 (26.1%) |
||
Cook |
38/96 (40%) |
21/96 (22%) |
64/96 (67%) |
- |
17/96 (18%) |
60% (58/96) |
25/96 (26%) |
63/96 |
17/96 (18%) |
||
(cervical spine |
(basilar |
GCS </= 8; |
(66%) |
||||||||
fracture) |
fracture w/ |
median GCS 3 |
|||||||||
carotid canal |
|||||||||||
involvement) |
|||||||||||
Desai |
2/8 (25%), PPV 0.09, NPV 0.95, Sn |
4/8 (50%), PPV 0.14, NPV 0.96, |
mean GCS, 8.67 =/- 6.22, |
1/8 (12.5%) |
1/8 (12.5%) |
3/8 (37.5%) |
- |
- |
1/8 (12.5%) |
||
0.25, Sp 0.84, |
Sn 0.50, Sp |
p = 0.2 |
|||||||||
p = 0.62 |
0.81, p = 0.05 |
||||||||||
(cervical spine |
|||||||||||
fracture.) |
|||||||||||
Dewan |
4/52 (7.7%) |
- |
26/52 (50%) |
3/52 (5.8%) |
16/52 (31%) |
18/62 (35%) |
- |
18/52 |
16/52 (31%) |
||
(GCS</=7) |
(35%) |
||||||||||
Farzaneh |
31/1998 (2%) |
129/1998 |
1149/1998 |
28/1998 (1.4%) |
- |
710/1998 (35.5%) |
- |
- |
- |
||
(cervical fracture) |
(6.5%) |
(57.5%) |
p < 0.01 |
p < 0.01 |
|||||||
p < 0.01; OR |
GCS < 6, OR |
||||||||||
1.004, CI |
0.99993, CI |
||||||||||
1.003-1.004, |
0.9993-0.9995, |
||||||||||
p < 0.01 (Any |
p < 0.001; |
||||||||||
skull fracture) |
mean GCS, 6.3 |
||||||||||
p < 0.01 |
|||||||||||
Grigorian |
31/109 (28.4%), |
58/109 (53.2%), |
49/109 (45.0%) |
24/109 (22.0%), |
3/109 (2.3%) |
58/109 (53.2%), |
10/109 (9.2%), |
- |
3/109 (2.3%) |
||
p < 0.001, OR |
p < 0.001, OR |
GCS </= 8, OR |
p < 0.001; OR |
OR 1.65, CI |
p < 0.001, OR |
||||||
3.15, CI 1.91-5.18, |
3.84, CI |
2.11, CI |
1.42, CI |
0.97-2.81, |
1.20, CI |
||||||
p < 0.001 |
2.40-6.14, |
1.33-3.54, |
0.88-2.29, |
p = 0.07 |
0.62-2.29, |
||||||
(cervical fracture); |
p < 0.001 |
p = 0.003; |
p = 0.15 |
p = 0.59 |
|||||||
5/109 (4.6%), |
median GCS 9, |
||||||||||
p < 0.001 |
p < 0.001 |
||||||||||
(cervical spine |
|||||||||||
injury) |
|||||||||||
Herbert |
3/21 (14.3%) |
- |
10/21 (47.6%) |
0/21 (0%) |
6/21 (28.6%) |
11/21 (52.4%) |
0/21 (0%) |
4/21 (19%) |
6/21 (28.6%) |
||
GCS </= 8 |
|||||||||||
Kopelman |
3/11 (27%), |
7/11 (64%), RR |
5/11 (45%) GCS |
1/11 (9%) |
4/11 (36%) |
6/11 (55%) |
0/11 (0%) |
2/11 (18%) |
4/11 (36%) |
||
RR 30.7 [9.8-96.4]; |
19.9 |
</= 8, RR 42.6 |
|||||||||
p < 0.001 |
[11.5-34.4], |
[18.1-100.4], |
|||||||||
(cervical fracture) |
p < 0.0001 |
p < 0.001 |
|||||||||
Leraas |
48/809 (5.9%) |
289/809 |
457/809 |
140/809 |
53/809 (6.6%), |
- |
264/809 |
- |
53/809 (6.6%), |
||
fracture; 27/809 |
(35.7%), OR |
(40.4%) GCS |
(17.3%) OR |
OR 1.0879, CI |
(32.6%), OR |
OR 1.0879, CI |
|||||
(3.3%) |
1.0072, CI |
</= 8, OR |
1.0002, CI |
1.0838-1.0919, |
1.0040, CI |
1.0838-1.0919], |
|||||
subluxation; |
1.0066-1.0078, |
1.0113, CI |
0.9998-1.0006, |
p < 0.001 |
1.0035-1.0045, |
p < 0.001 |
|||||
cervical fracture or |
p < 0.001 |
1.0108-1.0118, |
p = 0.212 |
p < 0.001 |
|||||||
subluxation |
p < 0.001 |
||||||||||
OR = 1.0058, CI |
|||||||||||
1.0052-1.0066 |
|||||||||||
p < 0.001 |
|||||||||||
Mallicote |
fracture, |
OR 3.0, CI |
GCS </= 8 not |
Not |
- |
- |
Not |
- |
- |
||
subluxation, |
2.6-3.5 |
an independent |
independent |
independent |
|||||||
dislocation OR 3.0, |
risk factor |
risk factor |
risk factor |
||||||||
CI 2.3-3.8; Cervical |
|||||||||||
Spine Fracture OR |
|||||||||||
3.6, CI 3.1-4.1; |
|||||||||||
Cervical Spine |
|||||||||||
Fracture w/ Cord |
|||||||||||
Injury OR 12.4, CI |
|||||||||||
10.2-15.2 |
|||||||||||
Ravindra |
2/36 (5.6%), |
6/36 (16.7%), |
26/36 (72.2%) |
- |
6/36 (16.7%), |
11/36 (30.6%) |
- |
10/36 |
6/36 (16.7%), |
||
(2015) |
p = 0.60 |
p = 0.80 |
GCS </= 8, |
p = 0.01; OR |
(27.8%), |
p = 0.01; OR |
|||||
(“associated spine |
p < 0.001; OR |
5.8, CI 1.5-21.8, |
p < 0.001; |
5.8, CI 1.5-21.8, |
|||||||
fractures”) |
2.9 CI 1.2-6.9, |
p = 0.01 |
OR 4.6, CI |
p = 0.01 |
|||||||
p = 0.020 |
1.6-13.0, |
||||||||||
p = 0.004 |
|||||||||||
Rossidis |
6/11 (54.5%), |
5/11 (45.5%), |
5/11 (45.5%) |
2/11 (18.2%), |
- |
- |
1/11 (9.1%), |
- |
- |
||
p < 0.0001 |
p < 0.0001 |
GCS </= 8, OR |
p < 0.0001 |
p < 0.0001; OR |
|||||||
cervical fracture; |
16.42, CI |
63.71, CI |
|||||||||
OR 36.88, CI |
2.16-102.33, |
2.16-1124.68, |
|||||||||
8.36-169.95, p < 0.0001 |
p = 0.0090; mean 8.2+/- |
0.0216 |
|||||||||
5.4, p = 0.0015 |
(continued on next page)
Table 3 (continued)
Source |
Risk Factor |
Outcomes |
|||||||||
Cervical spinal |
Basilar skull |
GCS (12) |
Soft tissue |
Stroke on |
Motor Vehicle |
Le Fort II/III |
Neurologic |
Stroke (12) |
|||
injury (16) |
fracture (13) |
injury of the |
imaging* (12) |
Collision/Accident |
fracture |
Deficit (7 |
|||||
neck (ie. |
(12) |
(midfacial |
or 8) |
||||||||
seatbelt sign) |
fracture) (10) |
||||||||||
(12) |
|||||||||||
Savoie |
307/1682 (18.3%) |
713/1689 |
- |
48/1682 |
53/1682 |
694/1682 |
237/1682 |
- |
53/1682 (3.15%) |
||
(42.4%) |
(2.85%) |
(3.15%) |
(motorcyclists and |
(14.1%) |
|||||||
car occupants); |
|||||||||||
9/1982 |
|||||||||||
(unspecified MVT) |
|||||||||||
Tolhurst |
7/7 (100%) |
- |
- |
- |
- |
4/7 (57.1%) |
6/7 (85.7%) |
||||
Ugalde |
23/53 (43.4%) |
26/53 (49.1%) |
27/53 (50.9%) |
11/53 (20.8%), |
10/53 (18.9%), |
31/53 (58.5%), |
- |
- |
10/53 (18.9%), |
||
p</=0.001; OR |
p = 0.01; OR |
GCS </= 8, |
p = 0.68 |
OR 3.95, CI |
p = 0.58 |
OR 3.95, CI |
|||||
3.63, CI 1.86-7.08, |
2.1, CI 1.08-4.1, |
p = 0.004 |
1.57-9.95, |
1.57-9.95, |
|||||||
p = 0.000 |
p = 0.03 |
p = 0.003 |
p = 0.003 |
||||||||
Weber |
13/42 (31.0%) |
13/42 (31.0%) |
- |
- |
2/42 (8.3%) |
(MVC) 35/42 |
“Facial injury” |
- |
2/42 (8.3%) |
||
p</=0.001; OR |
p = 0.020; OR |
(85.4%) p = 0.039 |
18/42 (42.9%); |
||||||||
8.2, CI 3.3-20.3, |
2.4, CI |
OR 4.4, CI |
|||||||||
p < 0.001 |
1.04-5.45, |
2.13-9.20, |
|||||||||
p = 0.039 |
p < 0.001 |
vehicle collision was also examined. Four studies examined the like- lihood of BCVI when >= 2 risk factors were present [13,15,21,22].
The results are summarized in Tables 1-5. In table C\\D, risk factors are organized left to right from most to least frequently studied, with risk factors that were included by less than four of the studies being ex- cluded from the tables. Ten studies found cervical spine fracture to be a significant risk factor for BCVI [11-19,22]. Ten studies found skull frac- ture to be a significant risk factor. Farzaneh found any skull fracture sig- nificant, Grigorian, Kopelman, Leraas, Mallicote, Savoie, Ugalde, and Weber found skull base/basilar skull fracture to be significant, and Her- bert and Ravindra found specific basilar Skull fractures, carotid canal and petrous temporal bone fractures, significant [10,12-14,16-20,22]. Five studies found depressed GCS score to be a significant risk factor. Desai found mean GCS score to be significantly lower in those with BCVI. Grigorian, Leraas and Kopelman found a GCS </=8 significant and Ravindra found GCS <8 significant [9,10,13,19,22]. Similarly, two stud- ies identified focal neurological deficit to be associated with BCVI [10,20]. Three studies found that mandible fractures were significantly associated with BCVI [13,16,19], and three studies found Le Fort II/III fa- cial fractures to be significant [13,15,16]. Weber describes “facial injury” as statistically significant [18]. Five studies found stroke to be a signifi- cant risk factor. Ravindra and Leraas simply identify stroke, while Grigorian mentions intracranial hemorrhage specifically and Herbert and Ugalde mention cerebral infarction specifically [10,13,17,19,20]. A high ISS is named by Weber, Ugalde, and Rossidis as a significant risk factor [15,17,18]. Ugalde and Leraas both find hanging mechanism sig- nificant, Farzaneh finds extremity fractures significant, and Leraas finds significant blood loss to be a significant association [12,13,17].
Notably, no studies examining the significance of soft tissue injury of the neck/seatbelt sign as an independent risk factor for BCVI found it to be significant [9,12-17,19,20,22].
Based on the Newcastle Ottawa Scale, all studies were rated as “good”. However, based upon the varying study populations, designs, and risk factors examined, we opted not to combine the results using meta-analysis.
Our systematic review of 16 studies of BCVI in pediatric patients revealed large variations in study population and screening criteria used/risk factors examined. The definition of a pediatric patient differed between studies, with some including all patients 18 years and younger
and others including only those under 16 or 15 years. One study chose not to include patients under 4, which excludes an important demo- graphic group of patients experiencing blunt trauma. Other notable differ- ences in the inclusion criteria were including using all admitted patients with blunt trauma,only those surviving 24 h, or only those who received imaging for BCVI. Additionally, several of the studies used the National Trauma Data Bank, leading to the likelihood that some patients are repre- sented in multiple studies when study periods overlap.
The risk factors or screening criteria examined in each study also varied greatly. The utilization of stroke differed between studies, with some including it as a risk factor and some as an outcome measure. If a stroke has been identified in the setting of pediatric trauma, it can be assumed that CTA imaging would be obtained. Future studies should include stroke only as an outcome measure to ensure clear imaging guidelines, as the goal of BCVI identification is to prevent secondary complications such as stroke. Due to the heterogeneity of risk factors ex- amined, outcome measures utilized across studies, and population overlap between multiple studies, we concluded that a meta-analysis was not practical. There is a need for further rigorous studies with greater standardization of data and distinct patient populations to fill knowledge gaps regarding BCVI risk factors in children.
Current BCVI screening tools in the pediatric population include the Utah score and the McGovern score. The Utah score awards points for GCS <=8, focal neurologic deficit, carotid canal fracture, petrous temporal bone fracture, and cerebral infarction on CT. The McGovern score uti- lizes the same screening criteria but adds an additional two points for mechanism of injury. In the study by Herbert, creators of the McGovern score found that the Utah score did not accurately predict BCVI in their cohort of patients and misclassified 47.6% as low risk [20]. Another mul- ticenter validation study also found a misclassification rate of 40.9% for the Utah score [24]. While the McGovern score in comparison had a misclassification rate of only 19%, there is an opportunity to increase the sensitivity for optimal screening guidelines [20]. Neither of these scores include cervical spine injury, which was found to be significant in several of the studies we examined in this paper. As with the adult screen- ing tools, systematic reviews can help to guide expansion or redefinition of screening criteria used in the pediatric population going forward. Al- though limited in children, there are multiple reviews of BCVI risk factors in adults. Since its development in the mid-90s, the Denver screening criteria has been examined by several systematic reviews that have helped refine its criteria over the years, including expansion of the criteria in 2011. Subsequent reviews, such as a 2018 review by Brommeland,
Table 4
Number of patients with BCVI who had each risk factor.
Source |
Risk Factor |
|||||||||
Intracranial injury* |
thoracic injury (6) |
ISS (6) |
>/=2 risk |
Mandible |
Hanging |
Fracture |
Petrous |
Thoracic |
||
(8) |
factors/screening |
fracture (5) |
mechanism (5) |
through |
temporal |
Fracture (4) |
||||
criteria* (5) |
carotid |
bone |
||||||||
canal (4) |
fracture |
|||||||||
(4) |
||||||||||
Azarakhsh |
- |
- |
- |
8/23 (34.8%) |
- |
- |
- |
- |
- |
|
Cook |
- |
0/96 (0%) |
median ISS, 34 |
- |
8/96 (8%) |
2/96 (2%) |
21/96 |
31/96 |
11/96 (11%) |
|
(40%) |
(31%) |
|||||||||
Desai |
5/8 (62.5%); PPV 0.16, |
- |
- |
- |
- |
- |
- |
- |
- |
|
NPV 0.95, Sn 0.63, |
||||||||||
Sp 0.67, p = 0.13 |
||||||||||
Dewan |
35/52 (67%) |
- |
- |
- |
- |
- |
17/52 |
7/52 |
- |
|
(33%) |
(13.5%) |
|||||||||
Farzaneh |
399/1998 (20%) |
94/1998 (4.7%) p < 0.01 |
1225/1998 |
- |
- |
- |
- |
- |
4/1998 |
|
(61.3%) |
(0.3%) |
|||||||||
ISS > 8 |
||||||||||
(646/1998 |
||||||||||
unknown ISS); |
||||||||||
mean ISS, 25.8, |
||||||||||
p < 0.01 |
||||||||||
Grigorian |
73/109 (67%) |
2/109 (1.8%) sternum |
median ISS 25, |
- |
13/109 |
0/109 (0%), |
- |
- |
12/109 |
|
p < 0.001; OR, 3.11; |
fracture, OR 2.26, CI |
p < 0.001 |
(11.9%), |
p = 0.97 |
(11.0%) |
|||||
95% CI, 1.89-5.14; |
0.51-10.05, p = 0.29; |
p < 0.001); |
p < 0.001); |
|||||||
p < 0.001 |
1/109 (0.9%) thoracic aorta |
OR, 1.99; |
OR 1.13, CI |
|||||||
injury, OR 1.58, CI |
95% CI, |
0.57-2.26, |
||||||||
0.17-14.30, p = 0.69; |
1.05-3.84; |
p = 0.72 |
||||||||
37/109 (33.9%) pulmonary |
p = 0.04 |
|||||||||
contusion, OR 1.15, CI |
||||||||||
0.67-1.95, p = 0.62; |
||||||||||
26/109 (23.9%) |
||||||||||
pneumothorax, OR 1.91, CI |
||||||||||
1.10-3.29, p = 0.02 (all |
||||||||||
incidence p < 0.001); 1/109 |
||||||||||
(0.9%) hemothorax, |
||||||||||
p = 0.07, OR 0.55, CI |
||||||||||
0.07-4.30, p = 0.57 |
||||||||||
Herbert |
14/21 (66.7%) |
- |
- |
- |
- |
- |
8/21 |
6/21 |
- |
|
(38.1%) |
(28.6%) |
|||||||||
Kopelman |
- |
7/11 (67%) |
- |
6/11 (55%) |
- |
- |
- |
- |
- |
|
Leraas |
- |
- |
- |
432/809 (53.4%) |
91/809 |
11/809 (1.4%), |
- |
- |
- |
|
(11.2%) |
OR 1.0118, CI |
|||||||||
1.0083-1.0153], |
||||||||||
p < 0.001 |
||||||||||
Mallicote |
OR 3.0, CI 2.0-4.4 |
- |
- |
OR 1.4, CI |
- |
- |
- |
- |
||
1.2-1.7 |
||||||||||
Ravindra |
5/36 (13.9%), |
- |
- |
- |
- |
0/36 (0%) |
16/36 |
5/36 |
- |
|
p = 0.90 epidural |
(44.4%), |
(13.9%), |
||||||||
hematoma; 11/36 |
p = 0.007; |
p = 0.17; |
||||||||
(30.6%), p = 0.69 |
OR 4.3, CI |
OR 6.8, CI |
||||||||
subdural |
1.7-10.8, |
1.9-24.6, |
||||||||
hematoma; 11/36 |
p = 0.002 |
p = 0.004 |
||||||||
(30.6%) p = 0.28 |
||||||||||
Rossidis |
- |
- |
8/11 (72.7%) |
7/11 (63.6%); RR |
- |
- |
- |
- |
- |
|
ISS>/=15, OR |
7.8, p < 0.0001 |
|||||||||
1.10, CI |
||||||||||
1.04-1.17, |
||||||||||
p = 0.0276; |
||||||||||
mean ISS 26.7 |
||||||||||
+-12.6, |
||||||||||
p = 0.0002 |
||||||||||
Savoie |
- |
- |
- |
- |
144/1682 |
- |
- |
- |
||
(8.56%) |
||||||||||
Tolhurst |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Ugalde |
33/53 (62.3%) |
- |
13/53 (24.5%) |
- |
- |
3/53 (5.7%) |
- |
- |
10/53 |
|
p = 0.02 |
ISS >15, |
p = 0.09, OR |
(18.9%) |
|||||||
p = 0.01; OR |
8.71, CI |
p = 0.20 |
||||||||
2.17, CI |
1.52-49.89, |
|||||||||
1.05-4.49, |
p = 0.015 |
|||||||||
p = 0.04 |
||||||||||
Weber |
“Head injury” 31/42 (73.8%) p = 0.028; |
33/42 (78.6%) p <=0.001 |
Mean = 39 p <=0.001; OR |
40/42 (95.2%) |
- |
- |
- |
- |
- |
|
OR 1.5, CI 0.54-4.05, |
1.05, CI |
|||||||||
p = 0.455 |
1.03-1.07, |
|||||||||
p < 0.001 |
Table 5
Number of patients with each risk factor that were diagnosed with BCVI
Source |
Risk Factor |
Outcome |
||||||||||||||||||
Cervical |
Basilar skull |
Motor |
GCS (6) |
Intracranial |
Le Fort II/III |
Soft tissue |
Neurologic |
Stroke on |
Hanging |
Thoracic |
Thoracic |
>/=2 risk |
Fracture |
ISS > 15 (2) |
Mandible |
Petrous |
Stroke (4) |
|||
spinal injury |
fracture |
Vehicle |
injury |
fracture |
injury of |
Deficit (5) |
imaging* |
mechanism |
Fracture |
injury |
factors/screening |
through |
fracture (2) |
temporal |
||||||
(11) |
(10) |
Collision/ |
(head |
(midfacial |
the neck |
(4) |
(3) |
(3) |
(3) |
criteria* (2) |
carotid |
bone |
||||||||
Accident |
trauma) * |
fracture) |
(ie. |
canal |
fracture |
|||||||||||||||
(7) |
(6) |
(6) |
seatbelt sign) (6) |
(2) |
(2) |
|||||||||||||||
Azarakhsh |
1/40 |
7/283 |
- |
- |
- |
0/40 |
4/93 |
0/18 |
- |
- |
- |
- |
8/63 |
- |
- |
- |
- |
- |
||
Desai |
2/23 (8.7%) |
4/28 |
- |
- |
5/32 (15.6%) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
2/23 |
||
(14.3%) |
(8.7%) |
|||||||||||||||||||
Farzaneh |
31/1699 |
129/33,139 |
710/184,887 |
1149/324,349 |
399/54,992 |
- |
28/2678 |
- |
- |
- |
4/1170 |
94/19,002 (0.49%) |
- |
- |
1225/296,293 |
- |
- |
- |
||
(1.8%) |
(0.39%) |
(0.38%) |
(0.35%) |
(0.73%) |
(1.0%) |
(0.34%) |
(0.41%) |
|||||||||||||
(any skull fracture) |
GCS < 6 |
|||||||||||||||||||
Grigorian |
31/1964 |
58/4949 |
58/11,384 |
49/2693 |
73/10,785 |
10/4329 |
- |
- |
- |
0/3 (0%) |
12/1286 |
2/146 (1.4%) sternum |
- |
- |
- |
13/999 |
- |
- |
||
(1.6%) (cervical |
(1.2%) |
(0.51%) |
(1.8%) GCS</=8 |
(0.68%) |
(0.23%) |
(0.93%) |
fracture; 1/33 (3.0%) thoracic aorta injury; |
(1.3%) |
||||||||||||
frac); 5/142 (3.5%) |
37/3351 (1.1%) |
|||||||||||||||||||
(cervical |
26/2184 (1.2%) |
|||||||||||||||||||
spine injury) |
pneumothorax; 1/125 (0.80%) hemothorax |
|||||||||||||||||||
Herbert |
- |
- |
11/220 |
10/143 (7.0%) |
- |
- |
- |
4/25 (16%) |
2/9 |
- |
- |
- |
- |
8/28 |
- |
- |
6/21 |
2/9 |
||
(5.0%) |
GCS</=8 |
(22.2%) |
(28.6%) |
(28.6%) |
(22.2%) of |
|||||||||||||||
those who |
||||||||||||||||||||
presented with |
||||||||||||||||||||
Kopelman |
3/13 (23%) |
7/41 (17%) |
- |
5/16 (31%) |
- |
none of this |
1/3 (33%) |
2/2 (100%) |
- |
- |
- |
- |
4/20 (20%) |
- |
- |
- |
- |
stroke - |
||
GCS</=8 |
injury in sample. |
|||||||||||||||||||
Ravindra |
2/18 (11.1%) |
6/37 |
11/60 |
26/108 |
5/31 (16.1%) |
- |
- |
10/24 |
6/14 |
0/18 (0%) |
- |
- |
- |
16/60 |
- |
- |
5/18 |
6/14 |
||
(16.2%) |
(18.3%) |
(24.1%) GCS</=8 |
epidural hematoma; |
(41.7%) |
(42.9%) (ischemic) |
(26.7%) |
(27.8%) |
(42.9%) |
||||||||||||
11/65 (16.9%) subdural |
||||||||||||||||||||
hematoma; |
||||||||||||||||||||
11.54 (20.4%) traumatic SAH |
||||||||||||||||||||
Rossidis |
6/151 |
5/567 |
- |
- |
- |
1/3 (33.3%) |
2/139 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
||
(3.97%) |
(0.88%) |
(1.4%) |
||||||||||||||||||
Savoie |
2.52% |
713/52,976 |
- |
- |
- |
237/13,047 |
48/26,402 |
- |
- |
- |
- |
- |
- |
- |
- |
144/14,756 |
- |
- |
||
(307/12201) |
(1.35%) |
(1.82%) |
(0.18%) |
(0.98%) |
||||||||||||||||
Tolhurst |
7/61 (11.5%) |
- |
4/31 (12.9%) |
- |
- |
- |
- |
6/20 (30%) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
||
Ugalde |
23/86 |
26/127 |
31/212 |
27/126 |
33/178 (18.5%) |
- |
11/86 |
- |
10/25 |
3/8 (37.5) |
10/50 |
- |
- |
- |
13/173 (7.5%) |
- |
- |
- |
||
(26.7%) |
(20.5%) |
(14.6%) |
(21.4%) |
(12.8%) |
(40.0%) |
(20%) |
||||||||||||||
Weber |
13/245 |
13/1353 |
35/5475 |
GCS</=8 - |
“Head injury” |
“Facial |
- |
- |
2/45 |
- |
- |
33/3438 (0.96%) |
- |
- |
- |
- |
- |
2/45 |
||
(5.3%) |
(0.96%) |
(0.64%) |
31/4573 |
injury” |
(4.4%) |
(4.4%) |
||||||||||||||
(0.68%) |
18/983 |
|||||||||||||||||||
(1.83%) |
helped to confirm the validity of this expanded criteria, and a 2019 review by Bensch has since suggested further augmentations [1,23]. Systematic reviews such as the review by Kim in 2020 continue to support the use of screening criteria for BCVI in adults [25].
These systematic reviews and meta-analyses have been applied to improve care for adult patients; however, their findings cannot be applied directly to the pediatric population. Differences in response to traumatic injury, developmental anatomy, and cerebrovascular reserve all contribute to different manifestations of BCVI than in adults. Anatomic differences such as disproportionately greater weight of the head, immature neck musculature, and higher ligamentous laxity increase forces placed on the head and neck during blunt trauma. Furthermore, children may have some anatomical protection from stroke as the presence of a complete Circle of Willis is greater in children, while an incomplete Circle of Willis increases significantly with age [26]. The latter may result in a decreasED capacity for collateral blood flow in the presence of a Large vessel occlusion. Not surprisingly, the risk of stroke in untreated BCVI in adults has been reported to be as high as 64% for Carotid artery injury (CAI) and 50% for vertebral artery injury (VAI) while the risk of stroke in untreated BCVI in children has been reported to be between 26 and 38%. [21,27-29]
Moreover, the Denver criteria, as well as the Memphis criteria, an- other commonly used adult-derived screening tool, include soft-tissue neck injury in their scores. Our current review did not find the cervical soft tissue injury or “seatbelt sign” to be associated with BCVI in chil- dren. A recent multi-center prospective study comparing the Denver, Memphis, EAST, Utah, and McGovern criteria/scores in a pediatric pop- ulation, found the Memphis score (which includes cervical spine fracture and basilar skull fracture) to be most sensitive, at 91.7%, but with the lowest specificity, at 71.1% [ 30]. While limited by the small number of BCVI in the cohort, further refining this rule by removing cervical soft tissue injury, for starters, may allow for in- creased specificity without significantly compromising sensitivity. An optimal decision rule in children would synthesize what we know from prior studies and use physiological characteristics spe- cific to children to inform a rule. The left and right internal carotid ar- tery arise from the Common carotid artery between the 3rd and 4th vertebral level and is most susceptible to blunt trauma at the cervical and petrous segments. It follows that both cervical spine and basilar skull fractures would be considered both anatomically and based on what many prior authors have determined.
Our study has limitations. We may have failed to identify all appro- priate studies to include in our review despite a comprehensive search strategy of multiple databases. The included papers were largely retro- spective cohorts with no randomized controlled trials. Although the results of observational studies may be influenced by confounders, they are the best representation of available data and therefore included. Additionally, patient overlap and lack of data standardization prevented meta-analysis of the data.
In conclusion, the available research is limited and includes data on a wide range of screening measures. The current review determined that basilar skull fracture, cervical spine injury, and GCS <8 are most com- monly found to be significantly associated with BCVI in children, while cervical soft tissue injury or “seatbelt sign” is not associated in any of the studies reviewed. A clear conclusion regarding what variables con- stitute significant risk factors to guide screening guidelines for BCVI in children is necessary and this systematic review, albeit without a meta-analysis, can be a starting point.
The authors of “Risk Factors for Blunt Cerebrovascular Injury in the Pediatric Patient: A Systematic Review,” Schulz, Weihing, Shah, Cox, and Ugalde, declare that they have no competing financial interests or personal relationships that affect this work.
Sources of support/Disclosures
None.
Prior presentations
N/A.
CRediT authorship contribution statement
Madison Schulz: Writing - review & editing, Writing - original draft, Visualization, Methodology, Investigation, Formal analysis, Data curation. Veronica Weihing: Writing - review & editing, Writing - original draft, Visualization, Methodology, Investigation, Formal analysis, Data curation. Manish N. Shah: Writing - review & editing, Writing - original draft. Charles S. Cox: Writing - review & editing, Writing - original draft. Irma Ugalde: Writing - review & editing, Writing - original draft, Supervision, Project administration, Methodology, Investigation, Conceptualization.
Declaration of Competing Interest
The authors report no conflicts of interest.
Appendix A. Publication search strategy
- Pediatrics/ or pediatric emergency medicine/
- Adolescent/ or exp. child/ or exp. infant/
- (“adolescen* or “child” or “infan*” or “teen*” or “youth*” or
“pediatric*” or “paediatric*”).ab,kf,kw,ti.
- 1 or 2 or 3
- Exp spinal fracture/ or exp. neck injuries/ or exp. cerebrovascular trauma/ or exp. carotid artery injuries/ or exp. vertebral artery dissec- tion/ or exp. vascular system injuries/
- (“cervical*vascular*injur*” or “cervical*injur*” or “vascular*injur*” or “cervical*vascular*trauma*” or “carotid*injur*” or “carotid*dissect*” or “carotid*trauma*” or “carotid*artery*injur*” or “carotid*artery*dissect*” or “carotid*artery*trauma*” or “vertebral*artery*injur*” or “vertebral*artery*dissect*” or “vertebral*artery*trauma*” or “cerebrovascular*trauma*” or “cerebrovascular*injur*”).ab,kf,kw,ti.
- Exp “intracranial embolism and thrombosis”/ or cerebral hemor- rhage, traumatic/ or intracranial hemorrhage, traumatic/ or stroke/ or Brain infarction/ or brain stem infarctions/ or infarction, anterior cere- bral artery/ or infarction, Middle cerebral artery/ or infarction, posterior cerebral artery/ or hemorrhagic stroke/ or exp. ischemic stroke/
- stroke*.ab,kw,ti.
- 5 or 6 or 7 or 8
- Wounds, nonpenetrating/ or contusions/.
- (“blunt*trauma*” or “blunt*injur*” or “non*penetrating*injur*”
or “non*penetrating*trauma*”).ab,kf,kw,ti.
- 10 or 11.
- Exp skull fractures/ or skull fracture, basilar/ or Spinal fractures/ or exp. neck injuries/ or whiplash injuries/ or soft tissue injuries/.
- Exp Neurologic manifestations/ or exp. spinal cord injuries/.
- (“neurologic*deficit*” or “seatbelt*sign*” or “neck*abrasion*” or “neck*soft*tissue*injur*” or “cervical*spin*injur*” or “cervical*spin*fracture*” or “basilar*skull*fracture*” or “hanging*” or “carotid*canal*fracture*” or “carotid*canal*injur*” or “petrous*temporal*bone*fracture*” or “petrous*bone*fracture*” or “temporal*bone*fracture*” or “neurologic*depression*” or “GCS” or “glasgow*coma*scale*” or “utah*score*” or “utah*screening*criteria*” or “ISS” or “mcgovern*screening*criteria*” or “injury*severity*score*”).ab, kf,kw,ti.
- 13 or 14 or 15.
- 4 and 9 and 12 and 16.
- Brommeland T, Helseth E, Aarhus M, et al. Best practice guidelines for blunt cerebro- vascular injury (BCVI). Scand J Trauma Resusc Emerg Med. 2018;26(1):90.
- Richards PJ, George J. Diagnostic CT radiation and cancer induction. Skeletal Radiol. 2010;39:421-4.
- Fullerton HJ, Johnston SC, Smith WS. Arterial dissection and stroke in children. Neu- rology. 2001 Oct 9;57(7):1155-60.
- Cook MR, Witt CE, Bonow RH, et al. A cohort study of blunt cerebrovascular injury screening in children: are they just little adults? J Trauma Acute Care Surg. 2018; 84(1):50-7.
- Dewan MC, Ravindra VM, Gannon S, et al. Treatment practices and outcomes after blunt cerebrovascular injury in children. Neurosurgery. 2016;79(6):872-8.
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021.;n71 Published online March 29.
- Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7(1):16.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9): 603-5.
- Desai NK, Kang J, Chokshi FH. Screening CT Angiography for pediatric blunt cerebro- vascular injury with emphasis on the cervical “seatbelt sign”. Am J Neuroradiol. 2014;35(9):1836-40.
- Ravindra VM, Riva-Cambrin J, Sivakumar W, Metzger RR, Bollo RJ. Risk factors for traumatic blunt cerebrovascular injury diagnosed by computed tomography angiog- raphy in the pediatric population: a retrospective cohort study. J Neurosurg Pediatr. 2015;15(6):599-606.
- Tolhurst SR, Vanderhave KL, Caird MS, et al. Cervical arterial injury after blunt trauma in children: characterization and advanced imaging. J Pediatr Orthop. 2013;33(1):37-42.
- Farzaneh CA, Schomberg J, Sullivan BG, et al. Development and validation of ma- chine learning models for the prediction of blunt cerebrovascular injury in children. J Pediatr Surg. 2022;57(4):732-8.
- Leraas HJ, Kuchibhatla M, Nag UP, et al. Cervical seatbelt sign is not associated with blunt cerebrovascular injury in children: a review of the national trauma databank. Am J Surg. 2019;218(1):100-5.
- Mallicote MU, Isani MA, Golden J, Ford HR, Upperman JS, Gayer CP. Screening for blunt cerebrovascular injuries in pediatric trauma patients. J Pediatr Surg. 2019;54 (9):1861-5.
- Rossidis AC, Tharakan SJ, Bose SK, Shekdar KV, Nance ML, Blinman TA. Predictors of pediatric blunt cerebrovascular injury. J Pediatr Surg. 2018;53(1):141-5.
- Savoie KB, Shi J, Wheeler K, Xiang H, Kenney BD. Pediatric blunt cerebrovascular in- juries: A national trauma database study. J Pediatr Surg. 2020;55(5):917-20.
- Ugalde I, Claiborne M, Cardenas-Turanzas M, Shah M, Langabeer J, Patel R. Risk fac- tors in pediatric Blunt cervical vascular injury and significance of seatbelt sign. West J Emerg Med. 2018;19(6):961-9.
- Weber CD, Lefering R, Weber MS, et al. Predictors for pediatric blunt cerebrovascular injury (BCVI): an international multicenter analysis. World J Surg. 2019;43(9): 2337-47.
- Grigorian A, Dolich M, Lekawa M, et al. Analysis of blunt cerebrovascular injury in pediatric trauma. J Trauma Acute Care Surg. 2019;87(6):1354-9.
- Herbert JP, Venkataraman SS, Turkmani AH, et al. Pediatric blunt cerebrovascular in- jury: the McGovern screening score. J Neurosurg Pediatr. 2018;21(6):639-49.
- Azarakhsh N, Grimes S, Notrica DM, et al. Blunt cerebrovascular injury in children: underreported or underrecognized? A multicenter ATOMAC study. J Trauma Acute Care Surg. 2013;75(6):1006-12.
- Kopelman TR, Berardoni NE, O’Neill PJ, et al. Risk factors for blunt cerebrovascular in- jury in children: do they mimic those seen in adults? J Trauma Inj Infect Crit Care. 2011;71(3):559-64.
- Bensch FV, Varjonen EA, Pyhalto TT, Koskinen SK. Augmenting Denver criteria yields increased BCVI detection, with screening showing markedly increased risk for sub- sequent ischemic stroke. Emerg Radiol. 2019;26(4):365-72.
- Ravindra VM, Bollo RJ, Sivakumar W, et al. Predicting blunt cerebrovascular injury in pediatric trauma: validation of the “Utah score”. J Neurotrauma. 2017;34(2):391-9.
- Kim DY, Biffl W, Bokhari F, et al. Evaluation and management of blunt cerebrovascu- lar injury: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020;88(6):875-87.
- Chopra T, Neuberger I, Prince E, et al. Age-related changes in the completeness of the circle of Willis in children. Childs Nerv Syst. 2022;38:1181-4.
- Burlew CC, Biffl WL. Blunt cerebrovascular trauma. Curr Opin Crit Care. 2010;16(6): 587-95.
- Cothren CC, Biffl WL, Moore EE, Kashuk JL, J.L.. Johnson treatment for blunt cerebro- vascular injuries: equivalence of anticoagulation and Antiplatelet agents. Arch Surg. 2009;144(7):685-90.
- Miller PR, Fabian TC, Bee TK, et al. Blunt cerebrovascular injuries: diagnosis and treatment. J Trauma. 2001;51(2):279-85.
- Nickoles TA, Lewit RA, Notrica DM, et al. Diagnostic accuracy of screening tools for pediatric blunt cerebrovascular injury: an ATOMAC multicenter study. J Trauma Acute Care Surg. 2023. https://doi.org/10.1097/TA.0000000000003888. Publish Ahead of Print.